Patents by Inventor Christopher Power

Christopher Power has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060189217
    Abstract: The subject invention relates to terminals that are utilized in bulb sockets for automotive lamp assemblies. The embodiments of the bulb sockets disclosed provide for superior alignment, electrical connection, and stabilization of the bulb in the bulb socket.
    Type: Application
    Filed: April 24, 2006
    Publication date: August 24, 2006
    Applicant: Guide Corporation
    Inventors: Christopher Powers, Paul Van Duyn, Ismael Garcia, David McMahan, Carey Marks
  • Publication number: 20050122734
    Abstract: An adverse weather headlamp assembly that comprises a foreground shield with two sides that taper up from a bottom portion to form a triangular shaped shield. The foreground shield can be movable between a blocking position and a pass-through position. In combination with a cutoff shield, the foreground shield reduces the amount of emitted light that can be reflected off of a wet or icy road in adverse weather conditions in order to reduce glare, while still allowing enough light to be emitted for the driver to adequately see the road.
    Type: Application
    Filed: December 4, 2003
    Publication date: June 9, 2005
    Applicant: Guide Corporation (a Delaware corporation)
    Inventors: Monty Foust, Christopher Powers, Jan Wisler
  • Patent number: 6737412
    Abstract: A synthetic nuclease resistant antisense oligodeoxynucleotide capable of selectively modulating expression of human tumor necrosis factor-alpha by targeting exon sequences flanking donor splice sites, thereby regulating expression of TNF-&agr; in a patient in need of such therapy is provided. In an embodiment either AS—ODN having the sequence set forth in SEQ ID No:4 or SEQ ID No:6 or a combination thereof can be used. The AS—ODN is administered either as the active ingredient in a pharmaceutical composition or by utilizing gene therapy techniques as an expression vector.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: May 18, 2004
    Assignees: Univerisity Technologies International, Inc., University of Manitoba
    Inventors: Christopher Power, Michael B. Mayne
  • Publication number: 20030083275
    Abstract: A synthetic nuclease resistant antisense oligodeoxynucleotide capable of selectively modulating expression of human tumor necrosis factor-alpha by targeting exon sequences flanking donor splice sites, thereby regulating expression of TNF-&agr; in a patient in need of such therapy is provided. In an embodiment either AS-ODN having the sequence set forth in SEQ ID No:4 or SEQ ID No:6 or a combination thereof can be used. The AS-ODN is administered either as the active ingredient in a pharmaceutical composition or by utilizing gene therapy techniques as an expression vector.
    Type: Application
    Filed: November 15, 1999
    Publication date: May 1, 2003
    Inventors: CHRISTOPHER POWER, MICHAEL B. MAYNE
  • Patent number: 6341519
    Abstract: In one embodiment, a gas-sensing probe for use in a combustor includes an elongated support member, a housing, a gas sensor and sensor wires. The housing is attached to an end of the support member, and the gas sensor is rigidly supported within the housing. In another embodiment, a gas-sensing probe for use in a combustor includes an elongated support member, a housing, and a gas sensor. The housing is removably attached to an end of the support member, and the gas sensor is disposed within the housing so that the gas sensor and housing are removable from the distal end of the support member as a unit. In another embodiment, a gas-sensing probe comprises an elongated support member, a gas sensor, and a calibration tube. The elongated support member has a proximal end and a distal end, and supports the gas sensor at the distal end thereof.
    Type: Grant
    Filed: October 5, 1999
    Date of Patent: January 29, 2002
    Assignee: Reuter-Stokes, Inc.
    Inventors: Mark J. Khesin, Leonid Izrailevskiy, Anatole J. Khesin, Christopher Power
  • Patent number: 6046319
    Abstract: A synthetic nuclease resistant antisense oligodeoxynucleotide capable of selectively modulating expression of human tumor necrosis factor-alpha by targeting exon sequences flanking donor splice sites, thereby regulating expression of TNF-.alpha. in a patient in need of such therapy is provided. In an embodiment either AS-ODN having the sequence set forth in SEQ ID No:4 or SEQ ID No:6 or a combination thereof can be used. The AS-ODN is administered either as the active ingredient in a pharmaceutical composition or by utilizing gene therapy techniques as an expression vector.
    Type: Grant
    Filed: October 22, 1998
    Date of Patent: April 4, 2000
    Assignee: University Technologies International, Inc.
    Inventors: Christopher Power, Michael B. Mayne
  • Patent number: 5573682
    Abstract: An improved nozzle for reducing overspray in high temperature supersonic plasma spray devices comprises a body defining an internal passageway having an upstream end and a downstream end through which a selected plasma gas is directed. The nozzle passageway has a generally converging/diverging Laval shape with its upstream end converging to a throat section and its downstream end diverging from the throat section. The upstream end of the passageway is configured to accommodate a high current cathode for producing an electrical arc in the passageway to heat and ionize the gas flow to plasma form as it moves along the passageway. The downstream end of the nozzle is uniquely configured through the methodology of this invention to have a contoured bell-shape that diverges from the throat to the exit of the nozzle. Coating material in powder form is injected into the plasma flow in the region of the bell-shaped downstream end of the nozzle and the powder particles become entrained in the flow.
    Type: Grant
    Filed: April 20, 1995
    Date of Patent: November 12, 1996
    Assignee: Plasma Processes
    Inventors: George P. Beason, Jr., Timothy N. McKechnie, Christopher A. Power
  • Patent number: 5249357
    Abstract: A process for making a combustion chamber for a rocket engine wherein a copper alloy in particle form is injected into a stream of heated carrier gas in plasma form which is then projected onto the inner surface of a hollow metal jacket having the configuration of a rocket engine combustion chamber. The particles are in the plasma stream for a sufficient length of time to heat the particles to a temperature such that the particles will flatten and adhere to previously deposited particles but will not spatter or vaporize. After a layer is formed, cooling channels are cut in the layer, than the channels are filled with a temporary filler and another layer of particles is deposited.
    Type: Grant
    Filed: January 27, 1993
    Date of Patent: October 5, 1993
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Richard R. Holmes, Timothy N. McKechnie, Christopher A. Power, Ronald L. Daniel, Jr., Robert M. Saxelby